Anu Garg, MD
Geriatric Medicine · Toledo, OHNPI 1336316306
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.2% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $136, more than ten times the $11 reported in 2019.
Across 15 payments — averaging $24.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi Pasteur Inc.$69
- AstraZeneca$52
- Otsuka America Pharmaceutical, Inc.$48
- Johnson & Johnson$33
- Novo Nordisk$32
- Eisai Inc.$29
- plus $105 from 6 others
What the payments were for
- Food & beverage$33691%
- Education$329%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi Pasteur Inc. | 3 | $69 |
| AstraZeneca | 1 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Johnson & Johnson | 1 | $33 |
| Novo Nordisk | 1 | $32 |
| Eisai Inc. | 1 | $29 |
| Lundbeck LLC | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| Biogen | 1 | $20 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $11 |
How this compares
$368 in reported general payments places this provider in the 65th percentile of 146 geriatric medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 496 | $186,827 |
| Invega SustennaPaliperidone Palmitate | 18 | $48,284 |
| TrulicityDulaglutide | 50 | $47,352 |
| XareltoRivaroxaban | 121 | $35,478 |
| MyrbetriqMirabegron | 109 | $34,300 |
| XifaxanRifaximin | 14 | $32,549 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 117 | $20,734 |
| JanuviaSitagliptin Phosphate | 40 | $18,727 |
| Incruse ElliptaUmeclidinium Bromide | 43 | $16,147 |
| JardianceEmpagliflozin | 46 | $15,718 |
| TradjentaLinagliptin | 48 | $15,081 |
| EntrestoSacubitril/Valsartan | 37 | $14,158 |
| FarxigaDapagliflozin Propanediol | 32 | $11,428 |
| LokelmaSodium Zirconium Cyclosilicate | 23 | $10,421 |
| Atorvastatin Calcium | 555 | $9,880 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Xarelto | $33 | $83,762139 claims |
| Lilly USA, LLCTrulicity, Olanzapine | $11 | $53,169243 claims |
| AstraZenecaFarxiga, Lokelma | $52 | $21,84955 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $14 | $5,66112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 146 geriatric medicine providers in Ohio.
Other geriatric medicine in Toledo
- Ammar KayyaliToledo$1K
- Cletus IwuagwuToledo$355
- Meenakshi PatelCenterville$644K
- Daniel CannoneWadsworth$423K
- Babak TousiCleveland$215K
- Brinder VijWest Chester$92K
- Sean CannoneCopley$74K
- Tai-Chi KwokWooster$26K
- James FidelholtzCincinnati$15K
- Rodney IsonCanal Fulton$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.